- Current report filing (8-K)
12 November 2010 - 7:05PM
Edgar (US Regulatory)
UNITED
STATES
|
SECURITIES
AND EXCHANGE COMMISSION
|
WASHINGTON,
D.C. 20549
|
|
FORM
8-K
|
|
CURRENT
REPORT
|
PURSUANT
TO SECTION 13 OR 15(d) OF THE
|
SECURITIES
EXCHANGE ACT OF 1934
|
|
|
Date
of report (Date of earliest event reported): November 11,
2010
|
|
|
BIO-BRIDGE
SCIENCE, INC.
|
(Exact
name of registrant as specified in its
charter)
|
|
|
|
DELAWARE
|
000-51497
|
20-1802936
|
(State
or other jurisdiction
|
(Commission
File Number)
|
(I.R.S.
Employer
|
of
incorporation or organization)
|
|
Identification
No.)
|
1801
South Meyers Road, Suite 220, Oakbrook Terrace, IL
|
60181
|
(Address
of Principal Executive Offices)
|
(Zip
Code)
|
630-613-9687
(Registrant’s
telephone number, including area code)
N/A
(Former
Name or Former Address, if Changed Since Last Report)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
o
Written communications pursuant to
Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule
14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications
pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act
(17 CFR 240.13e-
4(c))
|
|
|
Item
5.02.
|
|
Departure
of Directors or Certain Officers; Election of Directors; Appointment of
Certain Officers; Compensatory Arrangements of Certain
Officers.
|
(b) On
November 11, 2010, Chuen Huei (Kevin) Lee resigned, effective the same day, as
Chief Financial Officer of Bio-Bridge Science, Inc. Mr. Lee will
remain a consultant to the Company.
SIGNATURE
Pursuant to the requirements of the
Securities Exchange Act of 1934, as amended, the Registrant has duly caused this
report to be signed on its behalf by the undersigned hereunto duly
authorized.
|
Bio-Bridge
Science, Inc.
|
|
|
|
|
|
Date:
November 12, 2010
|
By:
|
/s/
Dr.
Liang Qiao
|
|
|
|
Name:
Dr.
Liang Qiao
|
|
|
|
|
|
|
|
|
|
Bio Bridge Science (CE) (USOTC:BGES)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Bio Bridge Science (CE) (USOTC:BGES)
Historical Stock Chart
Von Jul 2023 bis Jul 2024
Echtzeit-Nachrichten über Bio Bridge Science Inc (CE) (OTCMarkets): 0 Nachrichtenartikel
Weitere News-Artikel